期刊文献+

生长抑素治疗肝硬化上消化道出血68例临床观察 被引量:6

Clinical observation of somatostatin in the treatment of 68 cases of upper digestive tract bleeding caused by liver cirrhosis
下载PDF
导出
摘要 目的:探讨生长抑素治疗肝硬化上消化道出血的临床效果。方法:收治肝硬化上消化道出血患者68例,随机分为两组。对照组给予奥曲肽治疗,观察组在对照组基础上给予生长抑素治疗,比较两组临床效果。结果:观察组总有效率明显高于对照组,差异具有统计学意义(P<0.05)。观察组止血时间、输血量均少于对照组,差异具有统计学意义(P<0.05)。结论:生长抑素治疗肝硬化上消化道出血的临床效果较显著。 ObjectiveTo investigate the clinical effect of somatostatin in the treatment of upper digestive tract bleeding caused byliver cirrhosis.Methods:68 cases of patients with upper digestive tract bleeding caused by liver cirrhosis were divided into twogroups randomly.The control group was treated with octreotide.The observation group was treated with somatostatin based on thecontrol group.The clinical effects of the two groups was compared.Results:The total effective rate of the observation group wassignificantly higher than that of the control group,and the difference was statistically significant (P〈0.05).The bleeding time andblood transfusion in the observation group were less than those in the control group,and the differences were statisticallysignificant (P〈0.05).Conclusion:Somatostatin in the treatment of upper digestive tract bleeding caused by liver cirrhosis hadmore significant clinical effect.
出处 《中国社区医师》 2016年第33期42-42,44,共2页 Chinese Community Doctors
关键词 生长抑素 肝硬化 上消化道出血 Somatostatin Liver cirrhosis Upper digestive tract bleeding
  • 相关文献

参考文献6

二级参考文献44

  • 1王建军,靳雪源,程勇前,卿松,刘志国,赵平.生长抑素及奥曲肽治疗肝硬化上消化道出血致PT明显延长11例[J].中国肝脏病杂志(电子版),2010,2(4):26-27. 被引量:3
  • 2Hari Sayana,Osama Yousef,Wendell K Clarkston.Massive upper gastrointestinal hemorrhage due to invasive hepatocellular carcinoma and hepato-gastric fistula[J].World Journal of Gastroenterology,2013,19(42):7472-7475. 被引量:5
  • 3李兆申,湛先保.急性非静脉曲张性上消化道出血诊治指南(草案)[J].中华内科杂志,2005,40(1):73-76. 被引量:248
  • 4陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 5Tyden G, Sammegard H, Thulin L, et al. Treatment of bleeding esophageal varices with somatostatin[J]. N Engl J Med,1978,299:1466- 1467.
  • 6Reubi JC, Schaer JC, Laissue JA, et al. Somatostatin receptors and their subtypes in human tumor and in peritumom vessels[J]. Metabolism, 1996,45(Suppl 1):39-41.
  • 7Sonnenberg GE, Keller U, PerruehudA, et al. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects[J]. Gastroenterology,1981,80:526-532.
  • 8Nevens F. A critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage[J]. Aliment PharmacolTher,2004,20(Suppl 3): 18-22.
  • 9Villanueva C, Ortiz J, Minana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute varieeal bleeding[J]. Gastroenterology,2001,12 1: 110-117.
  • 10Spahr L, Giostra E, Frossard JL, et al. A 3-month outcome of long- acting repeatable oetreotide (sandostafin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study[J]. Am J Gastroenterol,2007, 102:1397-1405.

共引文献54

同被引文献45

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部